Global Registry
A4D-Ab
Afasevikumab
A4DAB008
|
Phase-I
Target
IL17A
Isotype / Subclass
G1 / None
Company
NovImmune
Genentech
Clinical Status
Phase-I
Format
Whole mAb
Synonyms
MCAF-5352A
MCAF5352A
NI-1401
NI1401
RG-7624
RG7624
RO5553110
pH Formulation
—
IMGT
PubChem (160671724)
PubChem (381127661)
PubChem (404772248)
PubChem (472408711)
PubChem (476262755)
PubChem (476269367)
Thera-SAbDab
YAbS
Avg A4D Score
-0.6878
Score Range
-0.7 to -0.68
Structures
2
Show Structure Profiles
Avg. A4D Score per Structure
pH at Min / Max Aggregation Propensity
Associated Structural Profiles
Level 2
Export CSV
Column Filters
Min Seq. Identity (%)
0
Min Avg A4D Score
-5.0
Max Avg A4D Score
2.0
Min pH (min agg. prop.)
0.0
Max pH (max agg. prop.)
14.0
Reset Filters
Structure ID
Source PDB
Seq. Identity
Avg. A4D Score
pH (Min Agg.)
pH (Max Agg.)
Score CDR
Score non-CDR
A4DAB008_6ppg_H_L
6ppg
100%
-0.6785
6.5
4.0
-0.3134
-0.7261
A4DAB008_6ppg_B_A
6ppg
100%
-0.6971
6.5
4.0
-0.3499
-0.7432